FTC sues big pharmacy gain professionals in excess of insulin price ranges The agency introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of life-saving insulin medication. Insurers will carry on vertically integrating to help keep extra income https://labelthefigurewiththeitem38383.myparisblog.com/31174055/not-known-details-about-healthcare-news